Annual Reports

2026 Annual Meeting of Stockholders Materials

Download item year list

Download Description

2025 Annual Report to Stockholders (opens in new window)

4.57 MB

2026 Proxy Statement (opens in new window)

607 KB

2026 PROXY SUPPLEMENT (opens in new window)

110 KB

Replay of the 2025 Annual Meeting of Stockholders (opens in new window)

Contact Us

JR DeVita

Send Email

Quick Links

SEC Filings
Investor FAQs
Events & Presentations

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Nuvation Bio Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Nuvation Bio Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options

Investor Alert Options *

News

Events & Presentations

Quarterly Reports

Annual Reports

SEC Filings

End of Day Stock Quote

Unsubscribe

Email Alert Sign Up Confirmation

Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment.

About us

Board of Directors
Management Team
Pipeline
Careers
Contact

General Inquiries

info@nuvationbio.com

Media or Investor Inquiries

IR@nuvationbio.com Visit us on LinkedIn

(Opens in new window)